ArTS Archivio della ricerca di Trieste

GENERALI, DANIELE

GENERALI, DANIELE  

Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute  

Docenti di ruolo di IIa fascia  

UnityFVG

6506309070

Mostra records
Risultati 1 - 20 di 296 (tempo di esecuzione: 0.059 secondi).
Titolo Data di pubblicazione Autori File
"Overcoming breast cancer drug resistance with mTOR inhibitors". Could it be a myth or a real possibility in the short-term future? 1-gen-2011 GENERALI, DANIELE +
A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection 1-gen-2023 Marina BortulDomenico TiernoDaniele GeneraliSerena ScomersiGabriele GrassiCristina BottinFabrizio ZanconatiBruna Scaggiante +
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 1-gen-2015 GENERALI, DANIELE +
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
A Phase II study of olaparib in breast cancer patients: Biological evaluation from a 'window of opportunity' trial 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Abemaciclib: A CDK4/6 inhibitor for the treatment of HR+/HEeR2- advanced breast cancer 1-gen-2018 Corona, Silvia PaolaGenerali, Daniele
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer 1-gen-2014 GENERALI, DANIELE +
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? 1-gen-2017 Generali, Daniele +
Advances in systemic therapy for malignant mesothelioma: Future perspectives 1-gen-2017 Sobhani, NavidCorona, Silvia PaolaBonazza, DeborahIanza, AnnaRoviello, GiandomenicoCortale, MaurizioGuglielmi, AlessandraZanconati, FabrizioGenerali, Daniele +
Advances in systemic therapy for metastatic breast cancer: future perspectives 1-gen-2017 Corona, S. P.SOBHANI, NAVIDIANZA, ANNAROVIELLO, GIANDOMENICOMUSTACCHI, GIORGIOBORTUL, MARINAZANCONATI, FABRIZIOGENERALI, DANIELE
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 1-gen-2023 Sobhani, NavidAldegheri, GiovanniRocca, AndreaGiudici, FabiolaBottin, CristinaZanconati, FabrizioGenerali, Daniele +
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial 1-gen-2016 Generali, Daniele +
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 1-gen-2021 Generali D. +
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 1-gen-2010 GENERALI, DANIELE +
Anti-inflammatory and anti-hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis-associated visceral pain 1-gen-2024 Generali, Daniele +
Apatinib for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib in metastatic gastric cancer: Can paclitaxel make the difference? 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Aromatase inhibitors: the journey from the state of the art to clinical open questions 1-gen-2023 Generali, Daniele +